Chemistry: molecular biology and microbiology – Vector – per se
Reexamination Certificate
2006-08-22
2006-08-22
Duffy, Patricia A. (Department: 1645)
Chemistry: molecular biology and microbiology
Vector, per se
C536S023700
Reexamination Certificate
active
07094597
ABSTRACT:
Vaccine compositions useful in inducing immune protection in a host against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis are disclosed. Each vaccine composition provides antigenic dnaJp1 peptide (by including the peptide or a polynucleotide which encodes the peptide) and, optionally, other peptide fragments of the microbial dnaJ protein and/or human homologs thereof. Methods for identifying persons who are predisposed to develop rheumatoid arthritis and methods for use of the inventive vaccines are also disclosed.
REFERENCES:
patent: 4654419 (1987-03-01), Vaughan et al.
patent: 4683295 (1987-07-01), Carson
patent: 4732757 (1988-03-01), Stolle et al.
patent: 5116725 (1992-05-01), Vaughan et al.
patent: 5310732 (1994-05-01), Carson et al.
patent: 5541164 (1996-07-01), Carson et al.
patent: 5728385 (1998-03-01), Classen
patent: 5773570 (1998-06-01), Carson et al.
patent: 5891435 (1999-04-01), Muir et al.
patent: 5922567 (1999-07-01), Au-Young et al.
patent: WO90/14835 (1990-12-01), None
patent: WO95/31984 (1995-11-01), None
Marshall. E., “Gene Therapy's Growing Pains”, Science, 269:1050-1055, Aug. 1995.
Miller et al, “Targeted Vectors for Gene Therapy”, FASEB J., 9:190-199, 1995.
NIH Report “Report and Recommendation of the Panel to Assess NIH Invetment in Gene Therapy Reseach”, Dec. 1995.
Bardwell et al., The Journal of Biological Chemistry, vol. 261, No. 4, pp. 1782-1785, 1986.
GenCore Accession # HHECDJ.
Albani, S., et al., “Positive Selection in Autoimmunity: Abnormal Immune Responses to a Bacterial dnaJ Antigen Determinant in Patients with Early Rheumatoid Arthritis,”Nature Medicine, vol. 1, No. 5, pp. 448-452, 1995.
Bonnin, D., et al., “MHC-Derived Peptides Drive Positive T Cell Selection in the Thymus: from a Physiological System to an HLA DRB1*0401 Transgenic Mouse Model for Rheumatoid Arthritis?”,Arthritis and Rheumatism, vol. 39, No. 9 Suppl., p. S160, Oct. 1996.
Auger, I., et al., “HLA-DR4 and HLA-DR10 Motifs that Carry Susceptibility to Rheumatoid Arthritis Bind 70-kD Heat Shock Proteins,”Nature Medicine, vol. 2, No. 3, pp. 306-310, Mar. 1996.
Albani, et al., “Genetics and Environmental Factors in the Immune Pathogenesis of Rheumatoid Arthritis,”Rheumatic Disease Clinics of North America, 18/4:729-740, 1992.
Stastney, P., et al., “Immunogenetics of Rheumatoid Arthritis and Juvenile Arthritis”,Recenti Progressi in Medicina, vol. 82, No. 7-8, pp. 409-416, 1991.
Nepom, G., “Prediction of Susceptibility to Rheumatoid Arthritis by Human Leukocyte Antigen Genotying”Rheumatic Disease Clinics of North America, vol. 18, No. 4, pp. 785-792, Nov. 1992.
Weyand, C., et al., “The Influence of HLA-DRB1 Genes on Disease Severity in Rheumatoid Arthritis,” Annals of Internal Medicine, vol. 117, No. 10, pp. 801-806, Nov. 15, 1992.
Fairchild, P., et al., “Peptide-MHC Interaction in Autoimmunity,”Current Opinion in Immunology, vol. 4, pp. 748-753, 1992.
Life, P.F., et al., “Synovial Fluid Antigen-Presenting Cells Unmask Peripheral Blood T Cell Responses to Bacterial Antigens in Inflammatory Arthritis,”Clin. Exp. Immunol.vol. 79, pp. 189-194, 1990.
Van Den Broek, M.F., et al., “Protection Against Streptococcal Cell Wall-Induced Arthritis by Pretreatment with the 65-kD Mycobacterial Heat Shock Protein,”J. Exp. Med., vol. 170, pp. 449-466, Aug. 1989.
Anderton, S.M., et al. “Activation of T Cells Recognizing Self 60-kD Heat Shock Protein Can Protect Against Experimental Arthritis,”J. Exp. Med., vol. 181, pp. 943-952, Mar. 1995.
Albani, S., et al., “A Multistep Molecular Mimicry Hypothesis for the Pathogenesis of Rheumatoid Arthritis,”Immunology Today, vol. 17, No. 10, pp. 466-470, Oct. 1996.
Anderton et al, “Differential Mycrobacterial 65-kDa Heat Shock Protein T Cell Epitope Recognition after Adjuvant Arthritis-Inducing or Protective Immunization Protocols1,”J. Immunology152:3656-64, 1994.
Albani et al, “HLA Binding Studies Support a Role for the QKRAA Susceptibility Sequence to Rheumatoid Arthritis (RA) in Positive Selection and Activation of Pathogenic T Lymphocytes,”Arthritis and Rheumatism, 38/9 Suppl., p. S181, Abstract#173, 1995.
Plotkin, S.A., et al., “New Technologies for Making Vaccines,”Vaccines, pp. 568-575, 1988.
Albani, S., et al., “Molecular Basis for the Association Between HLA DR4 and Rheumatoid Arthritis. From the Shared Epitope Hypothesis to a Peptidic Model of Rheumatoid Arthritis,”Clin. Biochem.vol. 25, pp. 209-212, 1992.
La Cava, A., et al., “The QKRAA Disease Susceptibility Sequence for Rheumatoid Arthritis (RA) is a B Cell Epitope Shared by the Epstein-Barr Virus (EBV) Protein gp110 and theE. coliHeat Shock Protein dnaJ Possible Implications for Disease Pathogenesis,”Arthritis&Rheum.36(9) Suppl. pp. S127 Abstract 1993.
Asseldonk, M., et al., “Cloning, Nucleotide Sequence, and Regulatory Analysis of theLactococcus lactisdnaJ Gene,”,Journal of Bacteriology, 175(6), pp. 1637-1644, Mar. 1993.
Bardwell, J.C.A., et al., “The Nucleotide Sequence of theEscherichia coliK12 dnaJ+ Gene,”The Journal of Biological Chemistry, vol. 261, No. 4, pp. 1782-1785, Feb. 5, 1986.
Ohki, M. et al., “Nucleotide Sequence of theEscherichia colidnaJ Gene and Purification of the Gene Product*”, The Journal of Biological Chemistry, vol. 261, No. 4, pp. 1778-1781, 1986.
Albani, S., et al., “The Susceptibility Sequence to Rheumatoid Arthritis in a Cross-Reactive B Cell Epitope Shared by theEscherichia coliHeat Shock Protein dnaJ and the Histocompatibility Leukocyte Antigen DRB10401 Molecule,”J. Clin. Invest., vol. 89, pp. 327-331, 1992.
van Eden, W., et al., “Cloning of the Mycobacterial Epitope Recognized by T Lymphocytes in Adjuvant Arthritis,”Nature, vol. 331, pp. 171-173, Jan. 14, 1988.
Silver, P.A., et al. “Eukaryotic DnaJ Homologs and the Specificity of Hsp70 Activity,”Cell, vol. 74, pp. 5-6, Jul. 16, 1993.
Zuber et al., “Cloning, Sequencing and Expression of the dnaJ gene ofCoxiella burnetii,” Gene, vol. 152 pp. 99-102, 1995.
DeGraeff-Meeder, E.R., et al., “Recognition of Human 60kD Heat Shock Protein by Mononuclear Cells from Patients with Juvenile Chronic Arthritis,”The Lancet, vol. 337, pp. 1368-1372, Jun. 8, 1991.
Brackertz et al, “OM-8980 in Rheumatoid Arthritis: A 6-Month Double Blind Placebo Controlled Multicenter Study,”Journal of Rheumatology, vol. 16, pp. 19-23, 1989.
Marsh, S.G.E., et al, “HLA Class II Nucleotide Sequences, 1991,”Tissue Antigens, vol. 37, pp. 181-189, 1991.
Albani, S., et al., “Immune Responses to theEscherichia colidnaJ Heat Shock Protein in Juvenile Rheumatoid Arthritis and their Correlation with Disease Activity,”The Journal of Pediatrics, vol. 124, No. 4, pp. 561-565, Apr. 1994.
GenCore Accession # HHECDJ.
Albani Salvatore
Carson Dennis A.
LandOfFree
Vaccine compositions and methods useful in inducing immune... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vaccine compositions and methods useful in inducing immune..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vaccine compositions and methods useful in inducing immune... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3669118